Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: J Immunol. 2011 Oct 26;187(11):5684–5692. doi: 10.4049/jimmunol.1101834

Figure 4. Susceptibility of DCs to killing by Treg cells.

Figure 4

(A) Sorted CD4+FoxP3+ Treg cells were cultured in vitro with anti-CD3- anti-CD28-coated Dynabeads in the presence of IL-2 for 0, 1, 2 or 3 days. BMDCs were labeled with CFSE and incubated with Treg cells for 6 h. Killing of DCs by Treg cells was determined as described in Materials and Methods. Day 3 versus day 0 at 0.3: and 1:1 Treg: DC ratios: **P<0.01 (n=3). (B) CD4+FoxP3+ Treg cells were sorted and stimulated with anti-CD3- anti-CD28-coated Dynabeads in the presence of IL-2 for 3 days. Treg-mediated killing (n=5) of BMDCs, splenic DCs, or activated B or T cells were was determined as described in Materials and Methods. (C) CD4+FoxP3+ Treg cells or CD4+FoxP3Teff cells sorted and expanded as in Fig. 3 were incubated with wild type or Bax−/−Bak−/− (DKO) BMDCs for 6 h, followed by staining with 7-AAD and analyses by flow cytometry. Loss of 7-AAD DCs was quantitated. WT versus DKO: **P<0.01 (n=3). (D) Killing of DCs by CD4+FoxP3+ Treg cells as in (A) in the presence of anti-MHC-II or control IgG. **P<0.01 (n=3). (E) CD4+FoxP3+ Treg cells or CD4+FoxP3 Teff cells were sorted from OT2/FoxP3GFP mice and expanded with OVA323–339 peptide-pulsed BMDCs for 3 days. OT2 Treg or Teff cells were then isolated by removing DCs with anti-CD11c-MACS beads (Miltenyi Biotec) and used for killing of BMDCs with or without pulsing with OVA323–339 peptide. WT versus DKO: **P<0.01 (n=3).

HHS Vulnerability Disclosure